Tubulocystic Renal Cell Carcinoma(TC-RCC), Collecting Duct Carcinoma(CDC), Papillary Renal Cell Carcinoma(P-RCC), Multilocular Cystic Renal Cell Carcinoma(MC-RCC), Cystic Nephroma(CN), Mixed Epithelial and Stromal Tumor of Kidney(MEST)
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients(Pts.) histopathologically diagnosed as TC-RCC, CDC, MC-RCC, CN, MEST from Jan 2005 to Mar 2016. 2. Pts. histopathologically diagnosed as P-RCC from Jan 2015 to Dec 2015. 3. Pts. Who were performed MDCT and / or MRI, followed resection within 6 months. 4. Pts. histopathologically definitive diagnosed. 5. Acceptable regardless of hospitalization, outpatient. 6. Acceptable regardless of gender.
Exclusion criteria
Exclusion criteria: 1. Pts. before surgery for renal tumors receiving chemotherapy surgery within six months ago. 2. Pts. receiving chemotherapy for renal tumors after CT or MRI. 3. Double registration of the same patient is prohibited. 4. Any other pts. who are determined ineligible for this study by investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Imaging features of Tubulocystic Renal Cell Carcinoma in comparison with Collecting Duct Carcinoma, Papillary Renal Cell Carcinoma, Multilocular Cystic Renal Cell Carcinoma, Cystic nephroma, and Mixed Epithelial and Stromal Tumor of Kidney. Descriptively summarize the following evaluation items on CT and MRI images among tumors; diameter, borderline, internal structure, necrosis, bleeding, invasion, calcification, venous tumor thrombus, dynamic pattern, CT index, Low intensity of T2, T2 STAR or SWI, observation of T1 in-opposed phase, observation of DWI, pathological staging, Bosniak classfication | — |
Secondary
| Measure | Time frame |
|---|---|
| Not applicable. | — |
Countries
Japan
Contacts
Institute and Graduate School of Biomedical Sciences. Hiroshima University Department of diagnostic radiology